Kenneth Anderson

Dr. Anderson is an internationally recognized researcher on multiple myeloma, the focus of his laboratory and clinical research studies over the last three decades. He has developed laboratory and animal models of the tumor in its microenvironment which have allowed for both identifications of novel targets and validation of novel targeted therapies and has then rapidly translated these studies to clinical trials culminating in FDA approval of novel targeted therapies. His paradigm for identifying and validating targets in the tumor cell and its milieu has transformed myeloma therapy and markedly improved patient outcomes. He is a recipient of many scientific and humanitarian awards including the International Myeloma Workshop Waldenstrom’s Award; the International Myeloma Foundation Robert A. Kyle Lifetime Achievement Award; the American Association for Cancer Research Joseph H. Burchenal Award; and the American Cancer Society Medal of Honor in Science. He is a member of the Institute of Medicine of the National Academy of Sciences, served as President of the International Myeloma Society, and is President-elect of the American Society of Hematology. Dr. Anderson is the Kraft Family Professor of Medicine at Harvard Medical School as well as Director of the Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute. He is a Doris Duke Distinguished Clinical Research Scientist and American Cancer Society Clinical Research Professor.